Nuwellis Inc (NUWE) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Nuwellis Inc (NUWE) has a cash flow conversion efficiency ratio of -0.804x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-3.15 Million) by net assets ($3.91 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Nuwellis Inc - Cash Flow Conversion Efficiency Trend (2003–2024)
This chart illustrates how Nuwellis Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Nuwellis Inc debt and liabilities for a breakdown of total debt and financial obligations.
Nuwellis Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Nuwellis Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Ampli SA w upadlosci ukladowej
WAR:APL
|
0.049x |
|
Fort St James Nickel Corp
V:FTJ
|
0.010x |
|
Sab Events & Governance Now Media Limited
NSE:SABEVENTS
|
-0.005x |
|
Tangiamo Touch Technology AB
ST:TANGI
|
0.021x |
|
Transforma Resources Corp
V:TFM
|
-0.010x |
|
Ondine Biomedical Inc
LSE:OBI
|
-0.665x |
|
MPAC Group PLC
LSE:MPAC
|
-0.028x |
|
Imalliance SA
PA:MLIML
|
N/A |
Annual Cash Flow Conversion Efficiency for Nuwellis Inc (2003–2024)
The table below shows the annual cash flow conversion efficiency of Nuwellis Inc from 2003 to 2024. For the full company profile with market capitalisation and key ratios, see NUWE stock market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $6.53 Million | $-9.59 Million | -1.469x | +73.71% |
| 2023-12-31 | $3.21 Million | $-17.94 Million | -5.586x | -355.66% |
| 2022-12-31 | $12.36 Million | $-15.15 Million | -1.226x | -78.27% |
| 2021-12-31 | $25.95 Million | $-17.84 Million | -0.688x | +32.29% |
| 2020-12-31 | $16.32 Million | $-16.57 Million | -1.016x | +87.65% |
| 2019-12-31 | $1.99 Million | $-16.37 Million | -8.225x | -235.31% |
| 2018-12-31 | $5.94 Million | $-14.56 Million | -2.453x | -234.14% |
| 2017-12-31 | $16.24 Million | $-11.92 Million | -0.734x | +92.08% |
| 2016-12-31 | $1.76 Million | $-16.29 Million | -9.273x | -390.92% |
| 2015-12-31 | $12.17 Million | $-22.99 Million | -1.889x | -143.69% |
| 2014-12-31 | $29.21 Million | $-22.64 Million | -0.775x | -130.92% |
| 2013-12-31 | $51.73 Million | $-17.36 Million | -0.336x | +66.78% |
| 2012-12-31 | $12.95 Million | $-13.08 Million | -1.010x | +64.52% |
| 2011-12-31 | $4.60 Million | $-13.09 Million | -2.848x | -85.26% |
| 2010-12-31 | $4.02 Million | $-6.18 Million | -1.537x | 0.00% |
| 2009-12-31 | $4.02 Million | $-6.18 Million | -1.537x | +59.74% |
| 2008-12-31 | $1.64 Million | $-6.25 Million | -3.819x | -314.53% |
| 2007-12-31 | $9.51 Million | $-8.76 Million | -0.921x | +25.15% |
| 2006-12-31 | $6.89 Million | $-8.48 Million | -1.231x | -14.82% |
| 2005-12-31 | $4.38 Million | $-4.70 Million | -1.072x | -61.61% |
| 2004-12-31 | $7.30 Million | $-4.84 Million | -0.663x | +92.54% |
| 2003-12-31 | $139.47K | $-1.24 Million | -8.886x | -- |
About Nuwellis Inc
Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter. The compan… Read more